BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10790426)

  • 1. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.
    Lich JD; Elliott JF; Blum JS
    J Exp Med; 2000 May; 191(9):1513-24. PubMed ID: 10790426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editing of an immunodominant epitope of glutamate decarboxylase by HLA-DM.
    Lich JD; Jayne JA; Zhou D; Elliott JF; Blum JS
    J Immunol; 2003 Jul; 171(2):853-9. PubMed ID: 12847254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens.
    Zhou D; Li P; Lin Y; Lott JM; Hislop AD; Canaday DH; Brutkiewicz RR; Blum JS
    Immunity; 2005 May; 22(5):571-81. PubMed ID: 15894275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis.
    Mukherjee P; Dani A; Bhatia S; Singh N; Rudensky AY; George A; Bal V; Mayor S; Rath S
    J Immunol; 2001 Sep; 167(5):2632-41. PubMed ID: 11509605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.
    Crotzer VL; Glosson N; Zhou D; Nishino I; Blum JS
    Immunology; 2010 Nov; 131(3):318-30. PubMed ID: 20518820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules.
    Pathak SS; Blum JS
    Traffic; 2000 Jul; 1(7):561-9. PubMed ID: 11208144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.
    Li P; Gregg JL; Wang N; Zhou D; O'Donnell P; Blum JS; Crotzer VL
    Immunol Rev; 2005 Oct; 207():206-17. PubMed ID: 16181338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification.
    Sinnathamby G; Eisenlohr LC
    J Immunol; 2003 Apr; 170(7):3504-13. PubMed ID: 12646611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides.
    Muntasell A; Carrascal M; Serradell L; Veelen Pv Pv; Verreck F; Koning F; Raposo G; Abián J; Jaraquemada D
    J Immunol; 2002 Nov; 169(9):5052-60. PubMed ID: 12391221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
    Dissanayake SK; Tuera N; Ostrand-Rosenberg S
    J Immunol; 2005 Feb; 174(4):1811-9. PubMed ID: 15699107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lysosomal cysteine proteases in MHC class II antigen presentation.
    Hsing LC; Rudensky AY
    Immunol Rev; 2005 Oct; 207():229-41. PubMed ID: 16181340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
    Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
    J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.
    Dani A; Chaudhry A; Mukherjee P; Rajagopal D; Bhatia S; George A; Bal V; Rath S; Mayor S
    J Cell Sci; 2004 Aug; 117(Pt 18):4219-30. PubMed ID: 15316082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.
    Rüssmann H; Panthel K; Köhn B; Jellbauer S; Winter SE; Garbom S; Wolf-Watz H; Hoffmann S; Grauling-Halama S; Geginat G
    Infect Immun; 2010 Dec; 78(12):5138-50. PubMed ID: 20876292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen secreted from noncytosolic Listeria monocytogenes is processed by the classical MHC class I processing pathway.
    Zwickey HL; Potter TA
    J Immunol; 1999 Jun; 162(11):6341-50. PubMed ID: 10352246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.
    Shim HK; Musson JA; Harper HM; McNeill HV; Walker N; Flick-Smith H; von Delwig A; Williamson ED; Robinson JH
    Immunology; 2006 Nov; 119(3):385-92. PubMed ID: 16919002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent.
    Tewari MK; Sinnathamby G; Rajagopal D; Eisenlohr LC
    Nat Immunol; 2005 Mar; 6(3):287-94. PubMed ID: 15711549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells.
    Basha G; Lizée G; Reinicke AT; Seipp RP; Omilusik KD; Jefferies WA
    PLoS One; 2008 Sep; 3(9):e3247. PubMed ID: 18802471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.